FST-344 (Follistatin 344) is a recombinant research protein widely studied for its role in regulating muscle growth, tissue development, and cellular signaling. As a naturally occurring glycoprotein, Follistatin binds to and inhibits members of the transforming growth factor-beta (TGF-β) superfamily, including myostatin (GDF-8) and activins. Through these interactions, FST-344 has become an important research tool for investigating the molecular pathways involved in skeletal muscle development, tissue regeneration, and metabolic regulation.
Scientific studies have explored FST-344 for its potential influence on muscle cell growth, protein synthesis, muscle regeneration, and recovery by modulating myostatin signaling. Researchers also investigate its role in connective tissue biology, cellular differentiation, exercise physiology, and the maintenance of muscle homeostasis. Ongoing laboratory research examines FST-344 in models of muscle-wasting disorders, regenerative medicine, and age-related declines in muscle function to better understand its effects on tissue repair and musculoskeletal health.
The FST-344 formulation provides researchers with a valuable tool for laboratory investigations into myostatin inhibition, muscle physiology, regenerative biology, TGF-β signaling, and cellular growth regulation. It remains an important research protein for advancing scientific knowledge of muscle development and tissue regeneration.
For research use only. Not intended for human consumption or therapeutic use.
Reviews
There are no reviews yet.